Afaf Khedr

Prof. Dr. Afaf Khedr

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2012 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
KOKamelia Osman
Kamelia Osman
MAMagdy Aly
Magdy Aly
AKAfaf Khedr
Afaf Khedr
KMKhaled Mabrok
Khaled Mabrok

3 November 2020 in Veterinary World
Verified
Journal Article
Open access
JEJ. El-Jakee
J. El-Jakee
MEMahmoud Elhariri
Mahmoud Elhariri
MEMona A. El-Shabrawy
Mona A. El-Shabrawy
AKAfaf Khedr
Afaf Khedr
RHRiham H. Hedia
Riham H. Hedia
EREman Ragab
Eman Ragab
Background and Aim: Chlamydia psittaci is an intracellular pathogen with a broad range of hosts and endemic in nearly all bird species as well as many mammalian species. Outbreaks contribute to economic losses, especially due to infection of pet birds, poultry, and livestock. Worse, the organism has a zoonotic effect, and transmission to humans results in severe illness. Therefore, proper control measures need to be applied. We conducted a trial for the preparation and evaluation of inactivated vaccine against C. psittaci. Materials and Methods: Three C. psittaci strains (accession nos.: KP942827, KP942828, and KP942829) were grown in embryonated chicken eggs and then propagated for purification in Vero cells. The immunization experiment was experimentally performed in mice, which then were challenged with a virulent C. psittaci strain. Results: The immunization trial revealed nearly 100% protection after the challenge. The histopathological and immunofluorescence examinations of internal organs revealed that the prepared killed vaccines can effectively reduce chlamydial infection and shedding in animals with the proper level of protection. Conclusion: Our vaccine can be used to control economic and financial losses resulting from avian chlamydiosis, especially those in poultry industries. The zoonotic transmission risk highlights the need for proper control measures.

1 January 2025 in Acta Veterinaria Eurasia
Verified
Journal Article
Open access
DODalia M. Omar
Dalia M. Omar
FGFatma M. Gadallah
Fatma M. Gadallah
MAMohamed A. Abdrabo
Mohamed A. Abdrabo
FGFatma Elzahraa Gamal
Fatma Elzahraa Gamal
NMNermin M. Monir
Nermin M. Monir
LOLamiaa M. Omar
Lamiaa M. Omar
Vaccination is a key control measure for most avian diseases, including the endemic Newcastle disease (ND), Mycoplasmosis, and Colibacillosis in Egypt. This study evaluated three inactivated monovalent commercial vaccines, one for each infection, and an inactivated trivalent locally prepared vaccine for the same diseases. The evaluation included challenge tests for the three diseases and monitoring of antibody levels using the hemagglutination inhibition test for ND and Enzyme-Linked Immunosorbent Assay (ELISA) for Mycoplasmosis. The trivalent vaccine showed protective percentages of 100%, 80%, and 80% against the three diseases, respectively. The monovalent commercial vaccines provided protections of 100%, 70%, and 70%, respectively. Hemagglutinating antibody titers for the trivalent vaccine were 6.9 and 6.5 log 2 at the second-week post-vaccination for LaSota and GVII antigens, respectively. In comparison, the monovalent commercial vaccine showed 4 log 2 at the first-week post-vaccination for LaSota antigen and 6.7 log 2 at the second-week post-vaccination for GVII antigen. The ELISA antibody titers for Mycoplasmosis in both trivalent and monovalent vaccines increased gradually from the first-week post-vaccination (1043 and 987) to peak at the seventh-week post-vaccination (2266 and 2226), respectively. In conclusion, the inactivated trivalent vaccine against ND, Mycoplasmosis, and Colibacillosis demonstrated high potency, efficacy, and safety. Cite this article as: Omar, D. M., Gadallah, F. M., Abdrabo, M. A., Gamal, F. E., Monir, N. M., Gamil, M. A. , Abdel Rahman, M. A. A., Marden, N. A., Abu Zaid, R. A., Abd El-Aziz, H. M. G., Khedr, A. A., & Omar, L. M. (2025). Immunological study on chickens vaccinated with a trivalent combined inactivated Mycoplasma gallisepticum, Escherichia coli, and newcastle disease virus (ND) vaccine. Acta Veterinaria Eurasia, 2025, 51, 0014, doi: 10.5152/actavet.2025.25014.